Harvard Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Harvard Bioscience

08/03/2022 14:32

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 8 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for earnings of 10 cents per share.
    * Revenue rose 6.7% to $33.06 million from a year ago; 
analysts
expected $32.96 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
2
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Harvard Bioscience Inc shares had fallen by 23.4% this
quarter.
    * The company reported quarterly net income of $961
thousand.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 8 at 02:32 p.m.  ​All
figures in US dollars unless otherwise stated